Send Inquiry

Request To Call Back

Erlocip 150 Mg Tablets

Name: Erlocip 150 Mg Tablets
Brand: Maheshwari Medical Agency
Price: 3200 INR
Availability: InStock

Price 3200 INR/ Bottle

Get a Price/Quote

MOQ : 1 Bottle

Erlocip 150 Mg Tablets Specification

Origin of Medicine
India

Life Span
24 Months (Shelf Life)

Brand Name
Erlocip

Packaging Type
Strip Packaging

Dosage Form
Oral

Pacakaging (Quantity Per Box)
30 Tablets per Box

Salt Composition
Erlotinib Hydrochloride

Indication
Approved for EGFR Mutation-Positive Non-Small Cell Lung Cancer and Pancreatic Cancer

Drug Type
Prescription Only

Ingredients
Erlotinib Hydrochloride

Physical Form
Tablets

Function
Anti-Cancer Medicine (Tyrosine Kinase Inhibitor)

Recommended For
Non-Small Cell Lung Cancer and Pancreatic Cancer Patients

Dosage
As Prescribed By Physician

Dosage Guidelines
Take One Tablet Once Daily or As Directed by Doctor

Suitable For
Adults

Quantity
1 Strip of 30 Tablets

Storage Instructions
Store at Room Temperature, Away from Moisture and Light

Warning
Not to be Used During Pregnancy or Breastfeeding Unless Prescribed

Color
White To Off-White

Therapeutic Class
Antineoplastic Agents

Route of Administration
Oral

Prescription/Non Prescription
Prescription

MRP
Mentioned on Pack

Storage Temperature
Below 30C (86F)

Side Effects
Rash, Diarrhea, Loss of Appetite, Nausea

Shape
Round, Film-Coated Tablet

Clinical Use
Targeted Cancer Therapy

Other Name
Generic Tarceva

Strength
150 mg

Erlocip 150 Mg Tablets Trade Information

Minimum Order Quantity
1 Bottle

Supply Ability
1000 Bottles Per Month

Delivery Time
7 Days

About Erlocip 150 Mg Tablets

Discover phenomenal value with Erlocip 150 Mg Tablets-an antineoplastic agent remarkably designed to target EGFR mutation-positive non-small cell lung cancer and pancreatic cancer. Manufactured in India and recognized as Generic Tarceva, these round, white to off-white, film-coated tablets offer competitive pricing with a significant price cut, bringing affordability and quality together. With a shelf life of 24 months, strength of 150 mg, and film-coated for ease of oral administration, Erlocip exemplifies outstanding efficacy for adults under prescription. MRP is mentioned on the pack for transparent, honest pricing.

Marvelous Features & Clinical Use of Erlocip 150 Mg Tablets

Erlocip 150 Mg Tablets function as a tyrosine kinase inhibitor, boasting remarkable efficacy for the treatment of non-small cell lung cancer and pancreatic cancer in adults. Used strictly under medical supervision, this prescription-only medicine offers a trusted solution for targeted cancer therapy. Each film-coated tablet is formulated with Erlotinib Hydrochloride, shaped round for optimal consumption, and distributed in convenient strip packaging of 30 tablets to ensure precise dosing and ease of storage.

Global Export Excellence and Supply Capabilities

Erlocip 150 Mg Tablets are shipped worldwide with stock ready for immediate dispatch, offering outstanding exporting ability for traders and medical suppliers. Our robust freight network ensures timely delivery, and supply is streamlined to meet high-volume demands across main export markets such as Asia, Africa, Latin America, and the Middle East. Clients benefit from reliable packaging-each box contains 30 tablets, maintaining product integrity throughout shipping and storage.

FAQ's of Erlocip 150 Mg Tablets:

Q: How should Erlocip 150 Mg Tablets be used for best results?

A: Erlocip 150 Mg Tablets should be taken orally once daily, as prescribed by your physician. It is crucial to follow the recommended dosage guidelines and not to self-adjust the dose without consulting a healthcare provider.

Q: What are the main therapeutic indications for Erlocip 150 Mg Tablets?

A: These tablets are primarily used for the treatment of EGFR mutation-positive non-small cell lung cancer and pancreatic cancer in adults, as part of a targeted cancer therapy regimen.

Q: When should this medication be stored or handled with extra care?

A: Erlocip 150 Mg Tablets should be stored below 30C (86F), in a cool, dry place, away from moisture and light. Always keep the tablets in their original strip packaging until use.

Q: Where are Erlocip 150 Mg Tablets manufactured and exported from?

A: Erlocip 150 Mg Tablets are manufactured in India and shipped to various global markets including Asia, Africa, Latin America, and the Middle East through trusted distributors and suppliers.

Q: What is the process for obtaining Erlocip 150 Mg Tablets?

A: As a prescription-only medicine, Erlocip 150 Mg Tablets must be prescribed by a licensed healthcare provider. The medication is typically distributed through registered pharmacies and verified medical suppliers.

Q: What are the prominent benefits of choosing Erlocip 150 Mg Tablets?

A: Erlocip 150 Mg Tablets offer competitive pricing, outstanding therapeutic efficacy, and strict quality standards. Patients receive a product with a remarkable track record in targeted cancer therapy, supported by reliable supply chains and professional distribution services.

Tell us about your requirement